Bronnen Barnes, Drake et al (2019). Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 34 (1):3–76 Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. (2019) Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet, 394: 939–51. Krause, Zhu et al (2018). Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis. European Neuropsychopharmacology, 28(6): 659–674 Leucht, Alessio Crippa et al (2020) Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. American Journal of Psychiatry, 177 (4): 342-353 McClellan (2018). Psychosis in Children and Adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 57(5):308–312 NICE (2013). Psychosis and schizophrenia in children and young people: recognition and management. National Institute for Care and Health Excellence, UK (update 2022) TagsDiagnose Praktijkstandaard